Kaili Jin

Dr. Kaili Jin

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 May 2025 in Current Oncology
Verified
Journal Article
Open access
PDF file
KJKaili Jin
Kaili Jin
XLXianlei Lin
Xianlei Lin
XXXiaoting Xia
Xiaoting Xia
HYHuiling Ye
Huiling Ye
DYDan Yang
Dan Yang
RWRongyun Wang
Rongyun Wang
Background: Platinum-based chemotherapy significantly increases the risk of nausea and vomiting, which can impair the treatment’s efficacy and the patient’s quality of life. This meta-analysis examines the incidence and risk factors of platinum-based chemotherapy-induced nausea and vomiting (PINV) in patients treated with this chemotherapy. Methods: This systematic review and meta-analysis were conducted in accordance with the PRISMA 2020 guidelines. We conducted a literature search in the databases PubMed, Embase, Web of Science, WanFang, China Science and Technology Journal Database (VIP), China National Knowledge Infrastructure (CNKI), and Chinese Medical Association Journal Database (CMAJD) through to 20 January 2025. Studies that reported the incidence and identified risk factors of nausea and vomiting specifically in patients receiving platinum-based chemotherapy were included in the review. The data were extracted independently by two reviewers. The odds ratios (ORs) for each risk factor were calculated from the included studies. Sensitivity analyses and additional subgroup analyses were performed to ensure the robustness of our findings. Results: This meta-analysis included 32 studies involving 14,207 participants. Female sex (OR = 2.363, 95% CI = 1.363–4.096, p = 0.002), anxiety (OR = 1.689, 95% CI = 1.057–2.700, p = 0.028), fatigue (OR = 1.413, 95% CI = 1.145–1.744, p = 0.001), motion sickness (OR = 1.816, 95% CI = 1.266–2.605, p = 0.001), and a history of vomiting during chemotherapy (OR = 2.728, 95% CI = 1.468–5.069, p = 0.002) were significantly associated with an increased risk of PINV. Conclusion: Female sex, anxiety, fatigue, motion sickness, and a history of vomiting during chemotherapy increase the risk of PINV during platinum-based treatments.

11 October 2026 in JMIR Preprints
Verified
Preprint
Open access
KJKaili Jin
Kaili Jin
RWRongyun Wang
Rongyun Wang
DYDan Yang
Dan Yang
QSQiuhua Sun
Qiuhua Sun
BACKGROUND Sarcopenia is characterized by declines in muscle strength, muscle mass, and physical function. Exercise and nutrition are key to its management, and digital delivery may enhance the accessibility of these interventions. OBJECTIVE To compare and rank digitally delivered exercise and nutritional strategies and estimate the incremental effects of intervention components using component network meta-analysis (CNMA). Methods: We searched comprehensive electronic databases from inception to July 27, 2026. Randomized controlled trials evaluating digitally delivered exercise and/or nutritional interventions in patients with sarcopenia were included. Risk of bias was assessed using RoB 2. Bayesian network meta-analysis was used to compare and rank different intervention strategies. Intervention components were prespecified and coded for CNMA, with incremental mean differences (iMDs) estimating the added benefit or harm of each component. METHODS We searched comprehensive electronic databases from inception to July 27, 2026. Randomized controlled trials evaluating digitally delivered exercise and/or nutritional interventions in patients with sarcopenia were included. Risk of bias was assessed using RoB 2. Bayesian network meta-analysis was used to compare and rank different intervention strategies. Intervention components were prespecified and coded for CNMA, with incremental mean differences (iMDs) estimating the added benefit or harm of each component. RESULTS Sixteen studies involving 1,355 participants were included. In the Bayesian NMA, digital exercise, digital nutrition, and combined digital exercise plus nutrition significantly improved handgrip strength (HGS) versus usual care, with MDs of 1.35 kg (95% CrI, 0.33 to 2.54), 2.07 kg (95% CrI, 0.06 to 4.27), and 2.21 kg (95% CrI, 1.15 to 3.56), respectively. In the additive CNMA, automated reminders/prompts had a positive incremental effect on appendicular skeletal muscle mass index (ASMI) (iMD, 1.71 kg/m²; 95% CI, 0.19 to 3.23; P = .027), whereas digital nutrition had a negative incremental effect (iMD, −0.97 kg/m²; 95% CI, −1.74 to −0.19; P = .015). Self-monitoring had a positive incremental effect on gait speed (iMD, 0.38 m/s; 95% CI, 0.16 to 0.60; P < .001). CONCLUSIONS Digitally delivered exercise and nutrition, particularly in combination, may improve handgrip strength in patients with sarcopenia. Automated reminders/prompts and self-monitoring showed positive incremental effects on ASMI and gait speed, respectively, whereas digital nutrition showed an unexpected negative effect on ASMI.